| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the rheumatic diseases 76 (6), 978-991, 2017 | 1853 | 2017 |
| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1180 | 2020 |
| Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores P Machado, R Landewé, E Lie, TK Kvien, J Braun, D Baker, ... Annals of the rheumatic diseases 70 (1), 47-53, 2011 | 835 | 2011 |
| Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ... Annals of the rheumatic diseases 77 (1), 3-17, 2018 | 714 | 2018 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 651 | 2021 |
| ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update S Ramiro, E Nikiphorou, A Sepriano, A Ortolan, C Webers, X Baraliakos, ... Annals of the rheumatic diseases 82 (1), 19-34, 2023 | 378 | 2023 |
| Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from … JC Branco, AM Rodrigues, N Gouveia, M Eusébio, S Ramiro, ... RMD open 2 (1), e000166, 2016 | 345 | 2016 |
| Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis P Machado, R Landewé, J Braun, KGA Hermann, D Baker, ... Annals of the rheumatic diseases 69 (8), 1465-1470, 2010 | 343 | 2010 |
| 2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations D van der Heijde, D Aletaha, L Carmona, CJ Edwards, TK Kvien, ... Annals of the rheumatic diseases 74 (1), 8-13, 2015 | 340 | 2015 |
| MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study JM Morrow, CDJ Sinclair, A Fischmann, PM Machado, MM Reilly, ... The Lancet Neurology 15 (1), 65-77, 2016 | 334 | 2016 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 316 | 2021 |
| EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 RBM Landewé, PM Machado, F Kroon, HWJ Bijlsma, GR Burmester, ... Annals of the rheumatic diseases 79 (7), 851-858, 2020 | 296 | 2020 |
| Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study A Moltó, A Etcheto, D Van Der Heijde, R Landewé, F Van Den Bosch, ... Annals of the rheumatic diseases 75 (6), 1016-1023, 2016 | 282 | 2016 |
| Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life … HY Chung, P Machado, D van Der Heijde, MA d'Agostino, M Dougados Annals of the rheumatic diseases 71 (6), 809-816, 2012 | 257 | 2012 |
| Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries MA Gianfrancesco, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... The Lancet Rheumatology 2 (5), e250-e253, 2020 | 245 | 2020 |
| MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group WP Maksymowych, RGW Lambert, M Østergaard, SJ Pedersen, ... Annals of the rheumatic diseases 78 (11), 1550-1558, 2019 | 242 | 2019 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 216 | 2021 |
| Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states PM Machado, R Landewé, D van der Heijde Annals of the rheumatic diseases 77 (10), 1539-1540, 2018 | 199 | 2018 |
| HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial … HY Chung, P Machado, D van Der Heijde, MA d'Agostino, M Dougados Annals of the rheumatic diseases 70 (11), 1930-1936, 2011 | 197 | 2011 |
| Rheumatic disease and COVID-19: epidemiology and outcomes KL Hyrich, PM Machado Nature Reviews Rheumatology 17 (2), 71-72, 2021 | 182 | 2021 |
Hanna MichaelUCL Institute of Neurology在 ucl.ac.uk 的电子邮件经过验证
